A Patient’s Perspective: The Value of an ADHD Diagnosis
The Carlat Psychiatry Report, Volume 4, Number 9, September 2006
Mr. H., now 49, was first diagnosed with ADHD at the age of 40, when he was evaluated at the suggestion of an old friend, a psychologist who had known him in grade school.
Gary S. Sachs, MD
Associate Professor of Psychiatry Harvard Medical School Director, Bipolar Clinic and Research Program Massachusetts General Hospital, Boston, Massachusetts
Dr. Sachs has disclosed that he is the recipient of research grants from Abbott, GlaxoSmithKline, Janssen, Repligen, Pfizer, and Wyeth; is a consultant for Abbott, AstraZeneca, Bristol-Myers Squibb, GlaxoSmithKline, Eli Lilly, Janssen, JDS, Memory, Repligen, Pfizer, Solvay, and Wyeth; and is a member of the speakers bureaus of Abbott, AstraZeneca, Bristol-Myers Squibb, GlaxoSmithKline, and Eli Lilly. The editors of The Carlat Psychiatry Report have reviewed the content of Dr. Goddard’s interview and have resolved any financial conflicts of interest regarding this educational activity.